GASTRIC ADENOCARCINOMA

This study is testing whether adding one or two new drugs to standard chemotherapy before surgery can better shrink tumors in people with advanced stomach or gastroesophageal cancer. The goal is to see if this approach helps more patients have no cancer cells left in the removed …

This study is testing whether injecting an experimental treatment called RP2 directly into stomach or esophagus tumors, along with standard chemotherapy (FLOT), is safe and works better than chemotherapy alone before surgery. Researchers want to see if this combination kills more…

This study aims to see if one of two different drug combinations can help shrink tumors before surgery for people with a specific type of advanced stomach or gastroesophageal cancer. About 30 participants will be randomly assigned to receive either an immunotherapy drug plus chem…

This is a first-in-human study testing a new oral drug called ACC-1898 in adults with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose and understand how the body processes the drug. Researchers will also look for early …

This study is for people with stomach cancer that has spread only to specific lymph nodes near the aorta. It tests if adding surgery and targeted radiation to standard chemotherapy and immunotherapy helps control the cancer longer. About 54 participants will be randomly assigned …

This early-stage study is testing the safety and feasibility of a new magnetic tracer, FerroTrace, used alongside a fluorescent dye to help surgeons better identify the lymph nodes most likely to contain cancer during stomach removal surgery. The goal is to improve the accuracy o…

This study tests if a guided exercise program, tracked by a smartwatch, can help reduce the severe fatigue many people experience after finishing chemotherapy for cancer. It will involve 98 adults who have recently completed treatment for certain cancers. Researchers will compare…

This study aims to understand if a simple stool test can help predict who is at higher risk for developing stomach cancer. Researchers will follow 3,000 people aged 40 and over for up to 10 years, comparing cancer rates between those with positive and negative test results. The g…

This study aims to understand how common early stomach cancer and precancerous changes are in India. It will enroll 4,000 adults aged 40+ who are already scheduled for a stomach scope. Researchers will use high-quality scopes and tissue analysis to create a detailed map of these …